Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
How Should We Manage Prostate Cancer Care by 2050?
6
Mins
April 2026
With an ever-growing world population and increasing life-expectancy, the incidence of different types of cancer is expected to rise in…
Read more
14
Mins
14 Sep 2023
Navigating Intermittent Catheterisation-Associated Complications
With a pre-specified aim of improving the standard of care of those living with intermittent catheter use, a roundtable discussion led by…
9
Mins
20 Apr 2023
Androgen Deprivation Therapy: Challenges and Future Perspective
This article details the use of androgen deprivation therapy in current clinical practice as discussed in an Accord Healthcare-sponsored symposium, delivered as part of the European Association of Urology (EAU) 38th Annual Congress held in Milan, Italy, between 10th–13th March 2023.
2
Mins
30 Mar 2023
Interview: Juan Gómez Rivas
Juan Gómez Rivas | Urology Consultant, Hospital Clinico San Carlos, Madrid, Spain; Assistant Professor, Universidad Complutense de Madrid, Spain
4
Mins
24 Mar 2023
Interview: Timothy Clinton
Timothy Clinton – Urologic Oncologist and Associate Surgeon, Dana–Farber Cancer Institute and Brigham and Women’s Hospitals, Boston, Massachusetts, USA; Faculty Member, Harvard University, Boston, USA.
6
Mins
15 Mar 2023
Interview Kari Tikkinen
Kari Tikkinen – Professor of Urology, Department of Surgery, University of Helsinki, Finland; Consultant Urologic Surgeon at the Department of Urology, Helsinki University Hospital, Finland and the Department of Surgery, South Karelian Central Hospital, Finland
4
Mins
13 Mar 2023
Interview: Bhaskar Somani
Bhaskar Somani – Professor and Consultant Urological Surgeon, University of Southampton, UK; Clinical Director of South Coast Lithotripter Services, UK; Endourology Lead, University Hospital Southampton, UK
4
Mins
8 Mar 2023
Interview: Ben Challacombe
Ben Challacombe |Consultant Urological Surgeon, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, UK. Having spent over 10 years in your current role with Guy’s and St Thomas’, what initially sparked your interest in urology and has pushed you to reach your established position today?
6
Mins
24 Feb 2023
Editor's Pick: Therapeutic Biomarkers for Bladder Carcinoma
Bladder cancer (BC) is the fourth most common malignancy in males and shows high prevalence and mortality rates worldwide despite improvements in its management.
4
Mins
21 Feb 2023
Unexplained Renal Impairment in a Patient With Seminoma
Testicular seminomas are the most common type of testicular germ cell tumours. It typically affects young males between the ages of 30–55 years. Because of its high sensitivity to chemotherapy and radiotherapy, these tumours have high cure rates.
3
Mins
23 Jan 2023
Urinary Bladder Stone: A Late Complication of Bulking Injection
Polyacrylamide hydrogel (PAHG) Bulkamid® (Axonics, Irvine, California, USA) was introduced in Europe as a promising periurethral bulking agent for the treatment of female stress and mixed urinary incontinence in 2006.
4
Mins
12 Dec 2022
Interview: Christopher Chapple
EMJ spoke to Christopher Chapple about his role as Secretary General of the European Association of Urology (EAU)…
11
Mins
26 Oct 2022
Recent Advances in the First-Line Management of Advanced Renal Cell Carcinoma: Focus on the Role of Lenvatinib Plus Pembrolizumab Combination Treatment
As part of the 37th Annual European Association of Urology (EAU) Congress, this symposium presented key data from the CLEAR study: a Phase III randomised controlled trial evaluating lenvatinib plus pembrolizumab versus sunitinib in patients with advanced renal cell carcinoma (RCC) in the first-line (1L) setting.
8
Mins
20 Sep 2022
Management of Acute and Recurrent Urinary Tract Infections Caused by Resistant Pathogens
At least 60% of females worldwide will experience at least one UTI in their lifetime.4 An array of pathogenic bacteria, both gram-negative and gram-positive, can cause the infections, although in uUTIs, Escherichia coli (E. coli) is the predominant pathogen.
9
Mins
15 Aug 2022
Improvements in Prostate Cancer Management: Focus on Imaging and Treatment
Imaging has a pivotal role in the staging of primary prostate cancer, as well as in determining optimal management strategies.
9
Mins
15 Aug 2022
Pigmentary Maculopathy in Interstitial Cystitis/Bladder Pain Syndrome Treated with Oral Pentosan Polysulfate: A Review
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition of unknown aetiology. Symptoms can vary but there is typically pelvic pain or discomfort perceived to be related to the urinary bladder, usually accompanied by other urinary symptoms such as the persistent urge to void or frequency.
10
Mins
15 Aug 2022
Advancing Patient Care in the Evolving Prostate Cancer Treatment Landscape
Prostate cancer varies at initial diagnosis and in its progression, with non-metastatic and metastatic presentations that may or may not respond to ADT (Figure 1).
8
Mins
15 Aug 2022
Interview: Prasanna Sooriakumaran
Prasanna Sooriakumaran | Lead for Urology and Consultant Urological Surgeon, Cleveland Clinic London, UK; Consultant Urological and Robotic Surgeon, University College London Hospitals; Honorary Senior Clinical Researcher, University of Oxford, UK.
5
Mins
13 Jul 2022
Primary Renal Hydatid in Children
Isolated renal hydatid disease, caused by the larvae of the parasitic tapeworm Echinococcus granulosus is a rare phenomenon and accounts…
4
Mins
11 Jul 2022
Laser Removal of Ureteral Stent Suture via Ureteroscopy
In this case, retrograde ureteroscopy with holmium laser on the retained suture proved an effective treatment in the removal of the stent.
5
Mins
16 May 2022
Editor's Pick: Penile Carcinoma in a Patient with Adenocarcinoma
Penile squamous cell carcinoma (SCC) is a rare malignancy associated with human papillomavirus and immunosuppression.
6
Mins
27 Apr 2022
The Debate on Prostate Cancer Screening
In the light of their journey through urological texts, the authors propose that the prostate screening collaborating with PSA measurements should continue..
9
Mins
22 Apr 2022
Prostate Artery Embolisation for Benign Prostatic Hyperplasia
BPH is the most common non-cancerous neoplasm of ageing males,1 increasing in incidence with age. The prevalence of BPH has been estimated…
6
Mins
28 Feb 2022
Robotic-Management for Renal Cell Carcinoma
At the authors’ institution, they prefer to use the robotic approach as it allows the trainees to hone their skills for other robotic procedures such as partial nephrectomies, nephroureterectomies, and pyeloplasties.
4
Mins
21 Feb 2022
Paget Disease of Skin Secondary to Urothelial Carcinoma
Currently, the exact mechanism underlying EMPD is unknown, but two widely known theories exist, namely the epidermotropic and transformation theories.
Loading posts...
« Previous
1
…
5
6
7
8
9
…
25
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View